Picture of Chemomab Therapeutics logo

CMMB — Chemomab Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Chemomab Therapeutics reports Q2 results

Aug 12 (Reuters) - Chemomab Therapeutics Ltd  CMMB.O :
    * CHEMOMAB THERAPEUTICS ANNOUNCES SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * CHEMOMAB THERAPEUTICS LTD - : CASH, CASH EQUIVALENTS AND
BANK
DEPOSITS WERE $51.8 MILLION AS OF JUNE 30, 2022, COMPARED TO
$57.5 MILLION AT MARCH 31, 2022
    * CHEMOMAB THERAPEUTICS LTD - CURRENTLY EXPECTS ITS RUNWAY
TO LAST
THROUGH END OF 2023, CONSISTENT WITH UPDATE PROVIDED LAST
QUARTER
    * CHEMOMAB THERAPEUTICS LTD - NET LOSS OF APPROXIMATELY
$0.03
CENTS PER BASIC AND DILUTED ORDINARY SHARE, FOR Q2 OF 2022

Source text for Eikon:  ID:nPn3Xwt3ka 
Further company coverage:  CMMB.O

Recent news on Chemomab Therapeutics

See all news